Equity News

How Did The ProQR Therapeutics (PRQR) Stock Rise 35% Pre-Hours?

After the company announced an expansion of cooperation, shares of ProQR Therapeutics N.V. (Nasdaq: PRQR) were up 35.15% at $2.23 at the time of our last check in pre-market trading. What partnership will PRQR be extending? Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics (PRQR) have expanded their license and partnership arrangement to concentrate more on the research and marketing of novel genetic treatments. The partnership, which was first disclosed in September 2021, used ProQR Therapeutics’ exclusive Axiomer RNA editing tool to treat liver and nervous system diseases. Since the beginning of the project, platform improvements have greatly improved